
Science submits BCI for vision restoration for CE mark
Brain-computer interface (BCI) developer Science Corporation today said it submitted its Prima retinal implant for CE mark approval.

Brain-computer interface (BCI) developer Science Corporation today said it submitted its Prima retinal implant for CE mark approval.

A team of Northwestern investigators have developed a wearable and wireless sleep monitoring device that provides an in-depth analysis of different sleep stages and may improve the detection of sleep disorders, detailed in a recent study published in the Proceedings of the National Academy of Sciences.

Endoscopies could be replaced by far less invasive capsule sponge tests for half of all patients with Barrett’s esophagus, a known precursor to esophageal cancer, according to a new study by researchers at the University of Cambridge, Addenbrooke’s Hospital and Queen Mary University of London. The research was published in The Lancet.

In a significant leap forward for successful cancer surgery, researchers at the University of Missouri and collaborators have developed a new imaging probe to help surgeons more accurately identify and remove aggressive tumors during operations.

Early childhood caries (ECC)—the world’s most prevalent chronic childhood disease—disproportionately targets specific teeth, a mystery that has remained unresolved until now.

The secrets of idiopathic pulmonary fibrosis (IPF) are written in its very name. Idiopathic refers to a disease of unknown cause, and the condition, which turns healthy lung tissue into fibrous scar tissue, still raises many questions.

The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet needs in screening to prevent the spread of infections in high-risk settings.

While many existing systems already pair continuous glucose monitors (CGMs) and insulin pumps, PharmaSens and SiBionics may have something different to offer.

Glucotrack (Nasdaq:GCTK) believes it can tap into a diabetes market that includes millions of people who aren’t being served completely.

Sequel Med Tech announced at the American Diabetes Association’s 85th Scientific Sessions in Chicago that it plans to launch its twiist system in July.